Trial intelligence / Profile preview

Opium Tincture for Chronic Diarrhea

NCT05690321Phase 2Completed

Start
Nov 2022
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of opium tincture in Chronic diarrhea (2 arms). Primary endpoint: Bowel movement frequency. Started Nov 2022; status: completed.

02

Drugs

opium tincture
03

Conditions

Chronic diarrhea

Beyond the preview

Go deeper on NCT05690321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05690321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call